Skip to content
OpenCapital
Get started

Intensity Therapeutics, Inc. INTS Q4 2024 Annual earnings

Reported March 13, 2025 · Before market open

EPS-$0.22Beat by $0.01
EPS estimate-$0.23

Next report

Aug 6, 2026 (In 1 week)
EPS estimate-$0.87

Versus estimates

Diluted EPS

Q1 2026-$0.96Beat by $0.23Q4 2025$1.69Beat by $2.93Q3 2025-$0.06In lineQ2 2025-$0.13Miss by $0.07Q1 2025-$0.22Miss by $0.01
Q4 2024-$0.22Beat by $0.01

Ask the moment Intensity Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Intensity Therapeutics, Inc. report Q4 2024 earnings?
Intensity Therapeutics, Inc. (INTS) reported Q4 2024 earnings on March 13, 2025 before market open.
What were Intensity Therapeutics, Inc.'s Q4 2024 revenue and EPS?
Intensity Therapeutics, Inc. reported eps of $-0.22 for Q4 2024.
Did Intensity Therapeutics, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.23 by $0.01.
Where can I find Intensity Therapeutics, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001567264-25-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.